WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 05-Dec-2014 (Data received as of 1-Dec-2014)
Next overall update June 2015
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 10'6501 Infant (under 12 months) mortality rate: 422
GDP / capita (US$): 19'2601 Child (under 5 years) mortality rate: 622

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 1'672  1'633  1'594  1'556  1'519  1'226  947  726 
Births 53  53  52  51  50  41  35  28 
Surviving infants 51  50  50  49  48  39  33  25 
Pop. less than 5 years 243  238  233  227  222  184  154  114 
Pop. less than 15 years 643  629  615  601  589  498  392  284 
Female 15-49 years 399  389  379  369  359  275  203  162 

Number of reported case

(Click for retrospective incidence data for Gabon)
Diphtheria
Japanese encephalitis
Measles 122  15  738  1'641 
Mumps
Pertussis 3'065 
Polio* 70 
Rubella 40 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total) 22  12 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Gabon)
Vaccine year result method % card seen                                                
BCG 2011  92  DHS   75  74  79  76  68  71  48  97 
DTP1 2011  88  DHS   75  80  86  82  93  81  24 
DTP3 2011  75  DHS   75  79  82  75  67  76  10  78 
HepB_BD         
HepB3 2011  65  DHS   75  79  82  75  67  79 
Hib3 2011  60  DHS   75  79  82  75  67 
JapEnc         
MCV 2011  74  DHS   75  70  71  72  62  63  27  76 
MCV2         
PCV1         
PCV3         
Pol3 2011  42  DHS   75  77  80  75  68  74  52  78 
Rota1         
Rota_last         
Rubella1         
TT2plus 2011  68  DHS   75  57  59  57  51  58  16  86 
PAB         
VAD1          70  30 
YFV 2011  68  DHS   75  69  71  71  61  67 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Gabon)
BCG 92  97  94  94  93  89  96 
DTP1 80  86  82  82  81  69  96 
DTP3 79  82  75  67  76  45  78 
HepB3 79  82  75  67  79 
HepB_BD
Hib3 79  82  75  67 
MCV 70  71  72  62  63  55  76 
MCV2
PAB 85  75  75  75  75  39  84 
PnC3
Pol3 77  80  75  68  74  44  78 
Rota_last
YFV 69  71  71  61  67 

Number of districts in the country 51  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 22
From 80 to 89% 12
From 50 to 79% 29
Less than 50% 37
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB , 10, 14 weeks; Yes
Measles 9 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
Pneumo_conj Yes From January 2015
Rotavirus Yes From 2017
TT 1st contact pregnancy; +1, +6 months; +1, +1 year; Yes
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  No  Yes  Yes  Yes  Yes  No 
What years does the MYP cover? number 2013-2017    2008-2011  2008-2011  2008-2011  2008-2011   
Nº of districts with microplans that include activities to raise immunization coverage number   50  37  25 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No    No       

System performance

Total Nº districts in country number 51  51  51  51  51  51  51 
Nº districts with DTP3 coverage >=80% number 17  20  14  11  26  21  12 
% of districts with DTP3 coverage >=80% From 0 to 100% 33  39  27  22  51  41  24 
Nº districts with measles (MCV1) coverage >=95% number  
% of districts with MCV1 coverage >=95% From 0 to 100% 10   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR No  No  No  No  No  No  No 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 100  100  100  100  100  100  100 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.